Jocelyn de Heer

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

Jocelyn de Heer, C.E. Rasmussen, D.H. Coy et al. · Diabetologia · 2008 · 237 citations · Full text

Receptor Subtype 2, Signal Transduction, Biochemistry +10

Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1

Jocelyn de Heer, Jens J. Holst · Diabetes · 2007 · 112 citations · Full text

Glucagon-like Peptide, Insulin Signaling, Gastrointestinal Peptide Hormone +17

Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade

Benedikt A. Aulinger, A Bedorf, G Kutscherauer et al. · Diabetes · 2013 · 92 citations · Full text

Gastroenterology, Incretin Pathway, Insulin Signaling +19

Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

Johana Norona, Petya Apostolova, Dominik Schmidt et al. · Blood · 2020 · 92 citations · Full text

GIP-(3–42) does not antagonize insulinotropic effects of GIP at physiological concentrations

Carolyn F. Deacon, Astrid Plamboeck, Mette M. Rosenkilde et al. · American Journal of Physiology-Endocrinology and Metabolism · 2006 · 68 citations

Synthetic Gip-, Insulin Signaling, Gastrointestinal Peptide Hormone +19